In this study, we demonstrated the antitumor effect of anti-PD-L1 antibody with lymphocyte infusion on established brain metastases in a hematogenous brain metastasis xenograft model using the human NSCLC cell line, Nluc-H1915. This evidence concerns the gene CD274 and non-small cell lung carcinoma.